CC-90001

N/A

Report date: 2026/03/11 20:02:12
NME

Base Information

Drug NameCC-90001
Drug Alias NameCC-90001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Actionc-Jun N-terminal kinase 1 inhibitors
Targetsc-Jun N-terminal kinase 1
Therapy Area/IndicationsSolid tumoursFibrosisPathologic Processes +[12] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesUkraine +[22] 
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesBristol Myers Squibb Srlcompany
Inactive CompaniesCelgene Corp
Active IndicationsSolid tumours
Inactive IndicationsFibrosisPathologic ProcessesIdiopathic Pulmonary Fibrosis +[11] 

Other Information

ATC CodeN/A
Related LinksN/A